Table of Content

1 Study Coverage
1.1 Anti-radiation Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anti-radiation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Potassium lodide (KI)
1.2.3 Prussian Blue
1.2.4 DTPA (Diethylenetriamine Pentaacetate)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-radiation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Acute Radiation Syndrome(ARS)
1.3.3 Cancer Treatment
1.3.4 Radiation Exposure
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-radiation Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Anti-radiation Drugs Revenue by Region
2.2.1 Global Anti-radiation Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Anti-radiation Drugs Revenue by Region (2018-2024)
2.2.3 Global Anti-radiation Drugs Revenue by Region (2024-2029)
2.2.4 Global Anti-radiation Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Anti-radiation Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Anti-radiation Drugs Sales by Region
2.4.1 Global Anti-radiation Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Anti-radiation Drugs Sales by Region (2018-2024)
2.4.3 Global Anti-radiation Drugs Sales by Region (2024-2029)
2.4.4 Global Anti-radiation Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anti-radiation Drugs Sales by Manufacturers
3.1.1 Global Anti-radiation Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Anti-radiation Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-radiation Drugs in 2022
3.2 Global Anti-radiation Drugs Revenue by Manufacturers
3.2.1 Global Anti-radiation Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Anti-radiation Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anti-radiation Drugs Revenue in 2022
3.3 Global Key Players of Anti-radiation Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Anti-radiation Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-radiation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-radiation Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-radiation Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Anti-radiation Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-radiation Drugs Sales by Type
4.1.1 Global Anti-radiation Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Anti-radiation Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Anti-radiation Drugs Sales Market Share by Type (2018-2029)
4.2 Global Anti-radiation Drugs Revenue by Type
4.2.1 Global Anti-radiation Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Anti-radiation Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Anti-radiation Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Anti-radiation Drugs Price by Type
4.3.1 Global Anti-radiation Drugs Price by Type (2018-2024)
4.3.2 Global Anti-radiation Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Anti-radiation Drugs Sales by Application
5.1.1 Global Anti-radiation Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Anti-radiation Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Anti-radiation Drugs Sales Market Share by Application (2018-2029)
5.2 Global Anti-radiation Drugs Revenue by Application
5.2.1 Global Anti-radiation Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Anti-radiation Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Anti-radiation Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Anti-radiation Drugs Price by Application
5.3.1 Global Anti-radiation Drugs Price by Application (2018-2024)
5.3.2 Global Anti-radiation Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Anti-radiation Drugs Market Size by Type
6.1.1 US & Canada Anti-radiation Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Anti-radiation Drugs Revenue by Type (2018-2029)
6.2 US & Canada Anti-radiation Drugs Market Size by Application
6.2.1 US & Canada Anti-radiation Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Anti-radiation Drugs Revenue by Application (2018-2029)
6.3 US & Canada Anti-radiation Drugs Market Size by Country
6.3.1 US & Canada Anti-radiation Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Anti-radiation Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Anti-radiation Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anti-radiation Drugs Market Size by Type
7.1.1 Europe Anti-radiation Drugs Sales by Type (2018-2029)
7.1.2 Europe Anti-radiation Drugs Revenue by Type (2018-2029)
7.2 Europe Anti-radiation Drugs Market Size by Application
7.2.1 Europe Anti-radiation Drugs Sales by Application (2018-2029)
7.2.2 Europe Anti-radiation Drugs Revenue by Application (2018-2029)
7.3 Europe Anti-radiation Drugs Market Size by Country
7.3.1 Europe Anti-radiation Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Anti-radiation Drugs Sales by Country (2018-2029)
7.3.3 Europe Anti-radiation Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anti-radiation Drugs Market Size
8.1.1 China Anti-radiation Drugs Sales (2018-2029)
8.1.2 China Anti-radiation Drugs Revenue (2018-2029)
8.2 China Anti-radiation Drugs Market Size by Application
8.2.1 China Anti-radiation Drugs Sales by Application (2018-2029)
8.2.2 China Anti-radiation Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Anti-radiation Drugs Market Size by Type
9.1.1 Asia Anti-radiation Drugs Sales by Type (2018-2029)
9.1.2 Asia Anti-radiation Drugs Revenue by Type (2018-2029)
9.2 Asia Anti-radiation Drugs Market Size by Application
9.2.1 Asia Anti-radiation Drugs Sales by Application (2018-2029)
9.2.2 Asia Anti-radiation Drugs Revenue by Application (2018-2029)
9.3 Asia Anti-radiation Drugs Sales by Region
9.3.1 Asia Anti-radiation Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Anti-radiation Drugs Revenue by Region (2018-2029)
9.3.3 Asia Anti-radiation Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-radiation Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Anti-radiation Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Anti-radiation Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Anti-radiation Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Anti-radiation Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Anti-radiation Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Overview
11.1.3 Amgen Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Amgen Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Recent Developments
11.2 Anbex
11.2.1 Anbex Company Information
11.2.2 Anbex Overview
11.2.3 Anbex Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Anbex Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Anbex Recent Developments
11.3 BTG International
11.3.1 BTG International Company Information
11.3.2 BTG International Overview
11.3.3 BTG International Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 BTG International Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BTG International Recent Developments
11.4 Cellphire
11.4.1 Cellphire Company Information
11.4.2 Cellphire Overview
11.4.3 Cellphire Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Cellphire Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cellphire Recent Developments
11.5 Chrysalis BioTherapeutics
11.5.1 Chrysalis BioTherapeutics Company Information
11.5.2 Chrysalis BioTherapeutics Overview
11.5.3 Chrysalis BioTherapeutics Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Chrysalis BioTherapeutics Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Chrysalis BioTherapeutics Recent Developments
11.6 Darnitsa
11.6.1 Darnitsa Company Information
11.6.2 Darnitsa Overview
11.6.3 Darnitsa Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Darnitsa Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Darnitsa Recent Developments
11.7 Enzychem Lifesciences
11.7.1 Enzychem Lifesciences Company Information
11.7.2 Enzychem Lifesciences Overview
11.7.3 Enzychem Lifesciences Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Enzychem Lifesciences Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Enzychem Lifesciences Recent Developments
11.8 Humanetics
11.8.1 Humanetics Company Information
11.8.2 Humanetics Overview
11.8.3 Humanetics Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Humanetics Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Humanetics Recent Developments
11.9 Mission Pharmacal
11.9.1 Mission Pharmacal Company Information
11.9.2 Mission Pharmacal Overview
11.9.3 Mission Pharmacal Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Mission Pharmacal Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Mission Pharmacal Recent Developments
11.10 Partner Therapeutics
11.10.1 Partner Therapeutics Company Information
11.10.2 Partner Therapeutics Overview
11.10.3 Partner Therapeutics Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Partner Therapeutics Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Partner Therapeutics Recent Developments
11.11 Myelo Therapeutics
11.11.1 Myelo Therapeutics Company Information
11.11.2 Myelo Therapeutics Overview
11.11.3 Myelo Therapeutics Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Myelo Therapeutics Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Myelo Therapeutics Recent Developments
11.12 Pluri
11.12.1 Pluri Company Information
11.12.2 Pluri Overview
11.12.3 Pluri Anti-radiation Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Pluri Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Pluri Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-radiation Drugs Industry Chain Analysis
12.2 Anti-radiation Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-radiation Drugs Production Mode & Process
12.4 Anti-radiation Drugs Sales and Marketing
12.4.1 Anti-radiation Drugs Sales Channels
12.4.2 Anti-radiation Drugs Distributors
12.5 Anti-radiation Drugs Customers
13 Market Dynamics
13.1 Anti-radiation Drugs Industry Trends
13.2 Anti-radiation Drugs Market Drivers
13.3 Anti-radiation Drugs Market Challenges
13.4 Anti-radiation Drugs Market Restraints
14 Key Findings in The Global Anti-radiation Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-radiation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Potassium lodide (KI)
Table 3. Major Manufacturers of Prussian Blue
Table 4. Major Manufacturers of DTPA (Diethylenetriamine Pentaacetate)
Table 5. Major Manufacturers of Others
Table 6. Global Anti-radiation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Anti-radiation Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Anti-radiation Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Anti-radiation Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Anti-radiation Drugs Revenue Market Share by Region (2018-2024)
Table 11. Global Anti-radiation Drugs Revenue Market Share by Region (2024-2029)
Table 12. Global Anti-radiation Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Anti-radiation Drugs Sales by Region (2018-2024) & (K Units)
Table 14. Global Anti-radiation Drugs Sales by Region (2024-2029) & (K Units)
Table 15. Global Anti-radiation Drugs Sales Market Share by Region (2018-2024)
Table 16. Global Anti-radiation Drugs Sales Market Share by Region (2024-2029)
Table 17. Global Anti-radiation Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Anti-radiation Drugs Sales Share by Manufacturers (2018-2024)
Table 19. Global Anti-radiation Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Anti-radiation Drugs Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Anti-radiation Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Anti-radiation Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Anti-radiation Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Anti-radiation Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-radiation Drugs as of 2022)
Table 25. Global Key Manufacturers of Anti-radiation Drugs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Anti-radiation Drugs, Product Offered and Application
Table 27. Global Key Manufacturers of Anti-radiation Drugs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-radiation Drugs Sales by Type (2018-2024) & (K Units)
Table 30. Global Anti-radiation Drugs Sales by Type (2024-2029) & (K Units)
Table 31. Global Anti-radiation Drugs Sales Share by Type (2018-2024)
Table 32. Global Anti-radiation Drugs Sales Share by Type (2024-2029)
Table 33. Global Anti-radiation Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Anti-radiation Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Anti-radiation Drugs Revenue Share by Type (2018-2024)
Table 36. Global Anti-radiation Drugs Revenue Share by Type (2024-2029)
Table 37. Anti-radiation Drugs Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Anti-radiation Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Anti-radiation Drugs Sales by Application (2018-2024) & (K Units)
Table 40. Global Anti-radiation Drugs Sales by Application (2024-2029) & (K Units)
Table 41. Global Anti-radiation Drugs Sales Share by Application (2018-2024)
Table 42. Global Anti-radiation Drugs Sales Share by Application (2024-2029)
Table 43. Global Anti-radiation Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Anti-radiation Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Anti-radiation Drugs Revenue Share by Application (2018-2024)
Table 46. Global Anti-radiation Drugs Revenue Share by Application (2024-2029)
Table 47. Anti-radiation Drugs Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Anti-radiation Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Anti-radiation Drugs Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Anti-radiation Drugs Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Anti-radiation Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Anti-radiation Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Anti-radiation Drugs Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Anti-radiation Drugs Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Anti-radiation Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Anti-radiation Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Anti-radiation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Anti-radiation Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Anti-radiation Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Anti-radiation Drugs Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Anti-radiation Drugs Sales by Country (2024-2029) & (K Units)
Table 62. Europe Anti-radiation Drugs Sales by Type (2018-2024) & (K Units)
Table 63. Europe Anti-radiation Drugs Sales by Type (2024-2029) & (K Units)
Table 64. Europe Anti-radiation Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Anti-radiation Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Anti-radiation Drugs Sales by Application (2018-2024) & (K Units)
Table 67. Europe Anti-radiation Drugs Sales by Application (2024-2029) & (K Units)
Table 68. Europe Anti-radiation Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Anti-radiation Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Anti-radiation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Anti-radiation Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Anti-radiation Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Anti-radiation Drugs Sales by Country (2018-2024) & (K Units)
Table 74. Europe Anti-radiation Drugs Sales by Country (2024-2029) & (K Units)
Table 75. China Anti-radiation Drugs Sales by Type (2018-2024) & (K Units)
Table 76. China Anti-radiation Drugs Sales by Type (2024-2029) & (K Units)
Table 77. China Anti-radiation Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Anti-radiation Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Anti-radiation Drugs Sales by Application (2018-2024) & (K Units)
Table 80. China Anti-radiation Drugs Sales by Application (2024-2029) & (K Units)
Table 81. China Anti-radiation Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Anti-radiation Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Anti-radiation Drugs Sales by Type (2018-2024) & (K Units)
Table 84. Asia Anti-radiation Drugs Sales by Type (2024-2029) & (K Units)
Table 85. Asia Anti-radiation Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Anti-radiation Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Anti-radiation Drugs Sales by Application (2018-2024) & (K Units)
Table 88. Asia Anti-radiation Drugs Sales by Application (2024-2029) & (K Units)
Table 89. Asia Anti-radiation Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Anti-radiation Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Anti-radiation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Anti-radiation Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Anti-radiation Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Anti-radiation Drugs Sales by Region (2018-2024) & (K Units)
Table 95. Asia Anti-radiation Drugs Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Anti-radiation Drugs Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Anti-radiation Drugs Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Anti-radiation Drugs Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Anti-radiation Drugs Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Anti-radiation Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Anti-radiation Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Anti-radiation Drugs Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Anti-radiation Drugs Sales by Country (2024-2029) & (K Units)
Table 109. Amgen Company Information
Table 110. Amgen Description and Major Businesses
Table 111. Amgen Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Amgen Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Amgen Recent Developments
Table 114. Anbex Company Information
Table 115. Anbex Description and Major Businesses
Table 116. Anbex Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Anbex Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Anbex Recent Developments
Table 119. BTG International Company Information
Table 120. BTG International Description and Major Businesses
Table 121. BTG International Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. BTG International Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. BTG International Recent Developments
Table 124. Cellphire Company Information
Table 125. Cellphire Description and Major Businesses
Table 126. Cellphire Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Cellphire Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Cellphire Recent Developments
Table 129. Chrysalis BioTherapeutics Company Information
Table 130. Chrysalis BioTherapeutics Description and Major Businesses
Table 131. Chrysalis BioTherapeutics Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Chrysalis BioTherapeutics Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Chrysalis BioTherapeutics Recent Developments
Table 134. Darnitsa Company Information
Table 135. Darnitsa Description and Major Businesses
Table 136. Darnitsa Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Darnitsa Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Darnitsa Recent Developments
Table 139. Enzychem Lifesciences Company Information
Table 140. Enzychem Lifesciences Description and Major Businesses
Table 141. Enzychem Lifesciences Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Enzychem Lifesciences Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Enzychem Lifesciences Recent Developments
Table 144. Humanetics Company Information
Table 145. Humanetics Description and Major Businesses
Table 146. Humanetics Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Humanetics Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Humanetics Recent Developments
Table 149. Mission Pharmacal Company Information
Table 150. Mission Pharmacal Description and Major Businesses
Table 151. Mission Pharmacal Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Mission Pharmacal Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Mission Pharmacal Recent Developments
Table 154. Partner Therapeutics Company Information
Table 155. Partner Therapeutics Description and Major Businesses
Table 156. Partner Therapeutics Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Partner Therapeutics Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Partner Therapeutics Recent Developments
Table 159. Myelo Therapeutics Company Information
Table 160. Myelo Therapeutics Description and Major Businesses
Table 161. Myelo Therapeutics Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Myelo Therapeutics Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Myelo Therapeutics Recent Developments
Table 164. Pluri Company Information
Table 165. Pluri Description and Major Businesses
Table 166. Pluri Anti-radiation Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Pluri Anti-radiation Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Pluri Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Anti-radiation Drugs Distributors List
Table 172. Anti-radiation Drugs Customers List
Table 173. Anti-radiation Drugs Market Trends
Table 174. Anti-radiation Drugs Market Drivers
Table 175. Anti-radiation Drugs Market Challenges
Table 176. Anti-radiation Drugs Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-radiation Drugs Product Picture
Figure 2. Global Anti-radiation Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Anti-radiation Drugs Market Share by Type in 2022 & 2029
Figure 4. Potassium lodide (KI) Product Picture
Figure 5. Prussian Blue Product Picture
Figure 6. DTPA (Diethylenetriamine Pentaacetate) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-radiation Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Anti-radiation Drugs Market Share by Application in 2022 & 2029
Figure 10. Acute Radiation Syndrome(ARS)
Figure 11. Cancer Treatment
Figure 12. Radiation Exposure
Figure 13. Others
Figure 14. Anti-radiation Drugs Report Years Considered
Figure 15. Global Anti-radiation Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Anti-radiation Drugs Revenue 2018-2029 (US$ Million)
Figure 17. Global Anti-radiation Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Anti-radiation Drugs Revenue Market Share by Region (2018-2029)
Figure 19. Global Anti-radiation Drugs Sales 2018-2029 ((K Units)
Figure 20. Global Anti-radiation Drugs Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Anti-radiation Drugs Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Anti-radiation Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Anti-radiation Drugs Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Anti-radiation Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Anti-radiation Drugs Sales YoY (2018-2029) & (K Units)
Figure 26. China Anti-radiation Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Anti-radiation Drugs Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Anti-radiation Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Anti-radiation Drugs Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Anti-radiation Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Anti-radiation Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Anti-radiation Drugs in the World: Market Share by Anti-radiation Drugs Revenue in 2022
Figure 33. Global Anti-radiation Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Anti-radiation Drugs Sales Market Share by Type (2018-2029)
Figure 35. Global Anti-radiation Drugs Revenue Market Share by Type (2018-2029)
Figure 36. Global Anti-radiation Drugs Sales Market Share by Application (2018-2029)
Figure 37. Global Anti-radiation Drugs Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Anti-radiation Drugs Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Anti-radiation Drugs Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Anti-radiation Drugs Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Anti-radiation Drugs Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Anti-radiation Drugs Revenue Share by Country (2018-2029)
Figure 43. US & Canada Anti-radiation Drugs Sales Share by Country (2018-2029)
Figure 44. U.S. Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Anti-radiation Drugs Sales Market Share by Type (2018-2029)
Figure 47. Europe Anti-radiation Drugs Revenue Market Share by Type (2018-2029)
Figure 48. Europe Anti-radiation Drugs Sales Market Share by Application (2018-2029)
Figure 49. Europe Anti-radiation Drugs Revenue Market Share by Application (2018-2029)
Figure 50. Europe Anti-radiation Drugs Revenue Share by Country (2018-2029)
Figure 51. Europe Anti-radiation Drugs Sales Share by Country (2018-2029)
Figure 52. Germany Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. France Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 57. China Anti-radiation Drugs Sales Market Share by Type (2018-2029)
Figure 58. China Anti-radiation Drugs Revenue Market Share by Type (2018-2029)
Figure 59. China Anti-radiation Drugs Sales Market Share by Application (2018-2029)
Figure 60. China Anti-radiation Drugs Revenue Market Share by Application (2018-2029)
Figure 61. Asia Anti-radiation Drugs Sales Market Share by Type (2018-2029)
Figure 62. Asia Anti-radiation Drugs Revenue Market Share by Type (2018-2029)
Figure 63. Asia Anti-radiation Drugs Sales Market Share by Application (2018-2029)
Figure 64. Asia Anti-radiation Drugs Revenue Market Share by Application (2018-2029)
Figure 65. Asia Anti-radiation Drugs Revenue Share by Region (2018-2029)
Figure 66. Asia Anti-radiation Drugs Sales Share by Region (2018-2029)
Figure 67. Japan Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. India Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Anti-radiation Drugs Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Anti-radiation Drugs Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Anti-radiation Drugs Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Anti-radiation Drugs Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Anti-radiation Drugs Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Anti-radiation Drugs Sales Share by Country (2018-2029)
Figure 78. Brazil Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Anti-radiation Drugs Revenue (2018-2029) & (US$ Million)
Figure 83. Anti-radiation Drugs Value Chain
Figure 84. Anti-radiation Drugs Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed